Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Arkansas Business Times.
Press releases published on June 2, 2025
Alpha Modus Holdings, Inc. CEO Affiliates To Exchange Preferred Stock for Common Stock, Demonstrating Confidence in Near Future Outlook
GlobeNewswire
·
June 2, 2025
CORNELIUS, N.C., June 02, 2025 (GLOBE NEWSWIRE) -- Alpha Modus Holdings, Inc. (NASDAQ: AMOD), a pioneer in AI-driven retail technology, today announced that CEO William Alessi’s affiliated family trusts have agreed to voluntarily exchange a substantial …
Mersana Therapeutics Reports Additional Positive Interim Phase 1 Clinical Data for Emi-Le in Oral Presentation at 2025 ASCO Annual Meeting
GlobeNewswire
·
June 2, 2025
31% confirmed ORR (8 responses in 26 evaluable patients) across B7-H4 high tumors at intermediate doses 44% confirmed ORR (7 responses in 16 evaluable patients) in the subset of patients with ≤4 prior lines of therapy CAMBRIDGE, Mass., June 02, 2025 (GLOBE …
IMUNON CEO RECAPS A YEAR OF CLINICAL ACHIEVEMENT AND SOLID FUNDAMENTALS
GlobeNewswire
·
June 2, 2025
Outstanding Phase 2 Results will be discussed at the 2025 ASCO in an Oral Presentation and featured in peer reviewed medical journal Gynecologic Oncology Phase 3 OVATION 3 Study in progress LAWRENCEVILLE, N.J. , June 02, 2025 (GLOBE NEWSWIRE) -- IMUNON, …
Joint Press Release of Constellation Software Inc. and Topicus.com Inc. -- Topicus.com Inc. completes acquisition of Cipal Schaubroeck in Belgium
GlobeNewswire
·
June 2, 2025
TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Constellation Software Inc. (TSX: CSU) and Topicus.com Inc. (TSXV: TOI) today announced that Topicus’ subsidiary Total Specific Solutions (TSS) B.V. (“TSS”) has completed the sale and transfer of all issued and …
Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer
GlobeNewswire
·
June 2, 2025
CORAL GABLES, Fla., June 02, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced the appointment of William (Will) T. Andrews, MD, FACP as Chief Medical Officer. Dr. Andrews will report directly …
Exhibit navigating the fight for liberty to open at the Hampton History Museum
GlobeNewswire
·
June 2, 2025
Hampton, Virginia, June 02, 2025 (GLOBE NEWSWIRE) -- In commemoration of the 250th Anniversary of the American Revolution, the Hampton History Museum’s newest exhibit explores the story of Hampton during the period. Revolutionary Hampton: Journeys of …
Liberty Defense Commences Normal Course Issuer Bid to Buy Back Up-to 9.9% of the Publically Traded Float
GlobeNewswire
·
June 2, 2025
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. WILMINGTON, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Liberty Defense Holdings Ltd. (“Liberty” or the “Company”) (TSXV: SCAN, OTCQB: LDDFF, FSE: E30), a leading …
CAPREIT to Invest in Canadian Housing Supply with Construction of 170 Residential Suites Within Existing Portfolio
GlobeNewswire
·
June 2, 2025
TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX:CAR.UN) announced today that it is planning to invest in two infill development projects for the construction of an estimated 120 …
Trust Wallet Launches Buy+, Powered by Binance Connect, to Simplify Crypto Access
GlobeNewswire
·
June 2, 2025
Users can buy tokens on BNB Chain, Base and Solana directly with cards, local currency and more - all without leaving the Trust Wallet app. DUBAI, United Arab Emirates, June 02, 2025 (GLOBE NEWSWIRE) -- Trust Wallet, the world’s leading self-custody Web3 …
Ghislain Houle, Executive Vice-President and Chief Financial Officer, to address Wells Fargo 2025 Industrials and Materials Conference
GlobeNewswire
·
June 2, 2025
MONTREAL, June 02, 2025 (GLOBE NEWSWIRE) -- Ghislain Houle, Executive Vice-President and Chief Financial Officer of CN (TSX: CNR) (NYSE: CNI), will address the Wells Fargo 2025 Industrials and Materials Conference on June 11, 2025, at 9:00 a.m. Eastern …
Ghislain Houle, vice-président exécutif et chef de la direction financière, prendra la parole lors de la Conférence sur les industriels et les matériaux 2025 de Wells Fargo
GlobeNewswire
·
June 2, 2025
MONTRÉAL, 02 juin 2025 (GLOBE NEWSWIRE) -- Ghislain Houle, vice-président exécutif et chef de la direction financière du CN (TSX : CNR) (NYSE : CNI), prendra la parole lors de la Conférence sur les industriels et les matériaux 2025 de Wells Fargo le 11 …
ASML reports transactions under its current share buyback program
GlobeNewswire
·
June 2, 2025
ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. Date Total repurchased shares Weighted average …
STMicroelectronics Announces Status of Common Share Repurchase Program
GlobeNewswire
·
June 2, 2025
STMicroelectronics Announces Status of Common Share Repurchase Program Disclosure of Transactions in Own Shares – Period from May 26, 2025 to May 30, 2025 AMSTERDAM – June 2, 2025 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a global …
Allarity Therapeutics Announces First Patient Enrolled in New Phase 2 Clinical Trial Protocol of Stenoparib in Advanced Ovarian Cancer
GlobeNewswire
·
June 2, 2025
TARPON SPRINGS, Fla., June 2, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway …
Kalaris to Present at Noble Capital Markets 2025 Emerging Growth Equity Conference
GlobeNewswire
·
June 2, 2025
PALO ALTO, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- Kalaris Therapeutics, Inc. (Nasdaq: KLRS) (“Kalaris”), a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases, today …
SELLAS Presents Preclinical Efficacy of SLS009 in ASXL1 Mutated Colorectal Cancer at 2025 ASCO Annual Meeting
GlobeNewswire
·
June 2, 2025
- ASCO Presentation Supports SLS009 as a Potential Targeted Therapy for ASXL1 Mutated Colorectal Cancer – - 22,500 New Cases of Colorectal Cancer with High Microsatellite Instability per Year in the US: 55% ASXL1m Frequency – NEW YORK, June 02, 2025 (GLOBE …
Sutro Biopharma Appoints Greg Chow as Chief Financial Officer
GlobeNewswire
·
June 2, 2025
SOUTH SAN FRANCISCO, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced the appointment of …
Xunlei Closes Acquisition of Hupu
GlobeNewswire
·
June 2, 2025
SHENZHEN, China, June 02, 2025 (GLOBE NEWSWIRE) -- Xunlei Limited ("Xunlei" or the "Company") (Nasdaq: XNET), a leading technology company providing distributed cloud services in China, today announced that it has closed the acquisition of Shanghai …
Freehold Royalties Announces Appointment of Chief Financial Officer
GlobeNewswire
·
June 2, 2025
CALGARY, Alberta, June 02, 2025 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold or the Company) (TSX:FRU) is pleased to announce the appointment of Shaina Morihira as its Chief Financial Officer, effective June 4, 2025. Ms. Morihira will succeed …
Humacyte Clinical Results in High-Risk Dialysis Patients from V007 Pivotal Phase 3
GlobeNewswire
·
June 2, 2025
DURHAM, N.C., June 02, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, announced that its abstract on the V007 …